Circulating miR-203 derived from metastatic tissues promotes myopenia in colorectal cancer patients.

Yoshinaga OkugawaYuji ToiyamaKeun HurAkira YamamotoChengzeng YinShozo IdeTakahito KitajimaHiroyuki FujikawaHiromi YasudaYuhki KoikeYoshiki OkitaJunichiro HiroShigeyuki YoshiyamaToshimitsu ArakiChikao MikiDonald C McMillanAjay GoelMasato Kusunoki

Published in: Journal of cachexia, sarcopenia and muscle (2019)

Assessment of serum miR-203 expression could be used for risk assessment of myopenia, and miR-203 might be a novel therapeutic target for inhibition of myopenia in CRC.

Keyphrases

cell proliferation
long non coding rna
long noncoding rna
poor prognosis
risk assessment
squamous cell carcinoma
small cell lung cancer
gene expression